BRIEF-Atara Bio receives ATMP classification for its EBV-CTLs product candidate from EMA

* Atara Bio receives advanced therapy medicinal product

classification for allogeneic epstein-barr virus specific

cytotoxic T-Lymphocytes (EBV-CTLs) from European Medicines

Agency (EMA)

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1 646 223 8780)

Read more